DMRA
$24.01
Post-MarketAs of Mar 17, 8:00 PM UTC
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
No recent news found.